Switzerland has confirmed its participation in the World Health Organization (WHO)’s COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
The government confirmed on September 18 its participation in the initiative to secure vaccines for 20% of the population, it said in a press releaseExternal link on Friday.
“In order to secure a fair distribution of Covid-19 vaccines across the globe, nations across the world have formed the COVAX initiative (COVID-19 Vaccine Global Access Facility) and created a pooled procurement mechanism,” it explained.
More than 60 higher income economies have joined COVAX, according to a September 21 WHO press releaseExternal link. It said more were expected to sign up in coming days. They are joined by 92 low- and middle-income economies eligible for support for the procurement of vaccines. The aim is to procure two billion doses of vaccines from a range of manufacturers by the end of 2021.
Funds, procurement
Switzerland will contribute CHF20 million ($22 million), according to the government press release. In addition, so-called self-financing countries – that is, higher-income countries such as Switzerland – may contribute additional funds to secure Covid-19 vaccines for their own populations.
Switzerland has also signed a contract with the US firm Moderna Therapeutics for the purchase of 4.5 million doses of vaccine and is in conversation with other vaccine manufacturers. Bern says joining the COVAX initiative is a complementary measure to these procurement efforts.
COVAX is co-led by the Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO. Switzerland has been among the initiative’s supporters from the beginning and, together with Singapore, has “led a group of likeminded countries to supervise the development of the COVAX Facility from the perspective of self-financing countries”.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
Ecological status of Swiss streams insufficient according to study
This content was published on
Pesticide use and obstructions of waterways have a particularly negative impact on sensitive organisms, completely absent in 70% of streams analysed.
Train line between Brig and Domodossola interrupted
This content was published on
One day after a derailment approximately 15 kilometres from the Swiss border, BLS is running buses for passengers between Preglia and Domodossola, in Italy.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid-19 vaccine: when, and for whom?
This content was published on
It’s the question we all want an answer to: when will there be a vaccine against Covid-19? And how is fair access being negotiated?
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.